<!DOCTYPE html>
<html lang="en">
<head>	
	<meta charset="UTF-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="viewport" content="width=device-width, initial-scale=1.0">
	<title>Email</title>

	<style type="text/css">
		body {
			margin: 0;
			background-color: black;
		}
		table {
			border-spacing: 0;
			font-family: arial;
			border:0 none; 
		}
		.wrapper {
			width: 100%;
			table-layout: fixed;
			background-color: black;
		}
		.webkit {
			max-width: 600px;
		}
		.outer{
			Margin: 0 auto;
			width: 100%;
			background-color: black;
		}
		@media screen and (max-width: 600px) { 
	
		}
	</style>
</head>
<body>
	<body>
		<center class="wrapper">
			<div class="webkit" >
					<table class="outer">
							<!-- Header SECTION -->

							<tr>
								<td >
									<table width="100%" style="border-spacing: 0;">
										<tr style="font-family: Arial;">
											<td style="font-size:5px" >
												<h1 style="color: white;" >Email</h1>
											</td>
										</tr>
									</table>
								</td>
							</tr>

							<!-- Spacing SECTION -->

							<tr style="height: 40px;">
								<td style="background-color: white;" >

								</td>
							</tr>

							<!-- Subject Line SECTION -->

							<tr style="background-color: white;">
								<td style="padding-left: 30px;">
									<table style="font-size: 15px;">
											<p style="color:#b5b5b5"><b>From:</b> DiscoverTIL@iovance.com</p>
											<p style="color:#b5b5b5"><b>Subject line:</b></p>
											<p style="color:#b5b5b5">Discover the science of tumor infiltrating lymphocytes (TIL) at DiscoverTIL.com</p>
											<p style="color:#b5b5b5">Alt: Find out about the science of tumor infiltrating lymphocytes (TIL) in multiple </p>
											<p style="color:#b5b5b5">solid tumors</p>
											<p style="color:#b5b5b5">Alt: Explore how tumor infiltrating lymphocytes (TIL) work naturally in the body</p>
									</table>
								</td>
							</tr>

							<!-- Discover Artwork SECTION -->

							<tr style="background-color: white;">
								<td >
									<table style="width: 600px;" >
												<img style="display:block;" width="100%" height="100%" src="images/discover1.PNG" />
									</table>
								</td>
							</tr>

							<!-- TIL Explained SECTION -->

							<tr style="background-color: white;">
								<td style="padding-left: 30px;">
									<table>
										<td style="color:#003a5d">
											<p>Tumor infiltrating lymphocytes (TIL) are part of the body’s</p>
											<p>natural response to cancer. For patients who have not </p>
											<p>responded to or who have progressed on immune </p>
											<p>checkpoint inhibitors, TIL are being investigated as a </p>
											<p>potential treatment option in multiple solid tumors.1-3</p>
										</td>
									</table>
									
								</td>
							</tr>	

							<!-- Button1 SECTION -->

								<tr style="background-color: white;">
									
									<td align="center">
										<table style="width: 300px;
										height: 100px;
										background-color:#003a5d;
										display:inline-block;
										border-radius: 10px;
										margin-left: auto;
										margin-right: auto;">
											<td style="color: white;">
												<p style="margin-left: 10px;"> <strong> Learn more about the </strong></p>
												<p style="margin-left: 10px;"> <strong> science of TIL </strong></p>
												<a href=""></a>
											</td>
											<td >
												<img src="images/Arrow.png" style="margin-left: 50px;">

											</td>
										</table>
									</td>
										
								</tr>
							
							<!-- IOVANCE SECTION -->

							<tr style="background-color: white;">
								<td style="padding-left: 30px;">
									<table>
										<td style="color:#003a5d">
											<p>IOVANCE Biotherapeutics is committed to deepening the </p>
											<p>understanding of TIL and optimizing TIL technology to help  </p>
											<p>shape the next chapter of TIL cell therapy.</p>
										</td>
									</table>
									
								</td>
							</tr>		

							<!-- References SECTION -->

							<tr style="background-color: white;">
								<td style="padding-left: 30px;">
									<table style="font-size: 8px;">
										<td style="color:#54585a">
											<p><strong> <b>References: 1.</b> Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive </strong></p>
											<p> immunotherapy of cancer with tumor-infiltrating lymphocytes. Science. </p>
											<p> 1986;233:1318-1321. <b>2.</b> Darvin P, Toor SM, Nair VS, Elkord E. Immune checkpoint </p>
											<p> inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):165.      </p>
											<p> <b>3.</b> Nowicki TS, Hu-Lieskovan S, Ribas A. Mechanisms of resistance to PD-1 and PD-L1 </p>
											<p> blockade. Cancer J. 2018;24(1):47-53. </p>
										</td>
									</table>
									
								</td>
							</tr>	

							<!-- Button2 SECTION -->

							<tr style="background-color: white;">
								<td align="center">
									<table style="width: 300px;
									height: 60px;
									background-color:white;
									display:inline-block;
									border-radius: 10px;
									margin-left: auto;
									margin-right: auto;
									border: #003a5d;
									 border-style: solid;
									  border-width: 3px;">
										<td style="color: #003a5d;">
											<p style="margin-left: 10px;"> <strong>Visit DiscoverTIL.com </strong></p>
											<a href=""></a>
										</td>
										<td>
											<img src="images/Arrow2.png" style="margin-left: 50px;">
										</td>
									</table>
								</td>
							</tr>
							<tr style="background-color: white;">
								<td>
									<table>
										<td style="vertical-align: top;">
											<img src="images/logo.PNG" alt="">	
										</td>
										<td style="font-size: 10px;">
											<p> CONTACT US | PRIVACY POLICY | UNSUBSCRIBE</p>
											<p style="height: 2px;"></p>
											<p> Iovance Biotherapeutics</p>
											<p> 999 Skyway Rd</p>
											<p> Suite 150 </p>
											<p> San Carlos, CA 94070</p>
											<p style="height: 2px;"></p>
											<p> © 2020 IOVANCE Biotherapeutics, Inc. All Rights Reserved.</p>
											<p> IOVANCE logo is a trademark owned by Iovance </p>
											<p>Biotherapeutics, Inc. </p>
											<p> PRC-US-00032(v1.0)</p>	
										</td>
									</table>
								</td>

							</tr>
								

					</table>
			</div>
		</center>	
	</body>

	

		



































	
</table>		
</body>
</html>